Background: Between 2012 and 2016, a total of 14 persons in Massachusetts with a history of substance use developed an unusual amnestic syndrome that included acute, complete, and bilateral hippocampal lesions on magnetic resonance imaging (1).
constitute the first cluster of this amnestic syndrome to be documented outside of Massachusetts. This wider distribution implies that physicians in other states should be aware of this syndrome when evaluating patients with new-onset amnesia, particularly those with a history of substance use.
The identity of the offending agent is uncertain. Of the 16 patients with this syndrome, 15 had previously used or tested positive for opioids (1, 2) . However, none was tested specifically for fentanyl even though this drug is frequently mixed with other opioids and is not usually detected on routine screening (3) . Therefore, to our knowledge, this report is the first to associate fentanyl with this amnestic syndrome. Although isolated cocaine use has been associated with a similar presentation (4), the history and toxicology results in 8 of the 16 reported patients showed no evidence of cocaine use (1, 2) .
When administered to rats, fentanyl may cause acute neuronal degeneration in the hippocampus and affiliated limbic structures in association with hippocampal hypermetabolism (5). These observations suggest that fentanyl and cocaine together potentiate the underlying mechanism of injury, including the potential for both excitotoxic and hypoxic-ischemic processes; such an interaction may also explain some of the lesions identified outside the hippocampus (for example, those in the globus pallidus) in this patient and others.
We believe that clinicians who encounter patients with new-onset amnesia, particularly in the setting of substance use, should consider including in their evaluation diffusionweighted magnetic resonance imaging of the head, routine toxicology screening, and neurologic consultation. When circumstances are consistent with this syndrome, we also suggest performing toxicology studies that are specific for fentanyl, its metabolites, and its analogues. 
